Inspired Shengsui aplastic anemia

Aplastic anemia (AA) acronym AA,
Due to a variety of reasons from hematopoietic stem cells, hematopoietic microenvironment injury, as well as changes in immune mechanisms, resulting in bone marrow hematopoietic failure, a blood cells to reduce the performance of the major diseases. The main pathological changes of red bone marrow fat. Under this priority disease onset, severity, extent and the vesting of bone marrow damage, domestic divided into two types of acute and chronic foreign-light and heavy two types. Although the incidence of all ages can, but common for young adults, more men than women, more than north south According to 21 provinces, municipalities and autonomous regions investigation, AA, the incidence rate 7.4/10 million.
AA at the incidence of congenital and acquired causes acquired two, congenital aplastic anemia or 2.5 percent, more than the incidence in the 10-year-old, the majority have family history, the fetal period may be affected by certain factors related. Acquired Acquired Aplastic Anemia, known as primary reasons unknown aplastic anemia, or 70.3 percent, were called to identify the reasons for secondary aplastic anemia, accounted for 16.9 percent. Secondary AA its causes as follows: 1) Drug factors, such as chloramphenicol, antipyretic analgesic agent, sulfonamides, tetracycline, anti-cancer drugs, deworming medicines ; 2) of ionizing radiation, such as X-ray and gamma-ray or neutron update can affect the cells, DNA and protein damage; 3) biological factors, after suffering from viral hepatitis secondary aplastic anemia, caused bacterial infection after blood cell reduction and AA; 4) Other factors, such as pregnancy can be complicated with aplastic anemia, physical factors such as paroxysmal nocturnal hemoglobinuria.
AA performance of the pathological changes in bone marrow hyperplasia reduce systemic red pulp of capacity reduction, fat pulp increased, but we will see hematopoietic stoves, stove hematopoietic cells can be seen in the composition, but there are more of lymphocytes and plasma cells, and other non - hematopoietic cell. Mesenchymal have edema, focal hemorrhage, and macrophages RBC phenomena such as Hemosiderosis.
Another barrier to the clinical manifestations anemia, bleeding and infection, dizziness due to anemia, there will be weak, alarming shortness of breath and looking pale, and other symptoms. More hemorrhage due to thrombocytopenia can be manifested as skin mucosal bleeding, women menorrhagia due to reduced neutrophil fever can be caused by infection, laboratory examination showed decreased blood cell, neutrophil classification has reduced lymphocyte increase reticulocyte RBC reduced, often <1%, the general without splenomegaly.
Another barrier to the treatment of Western medicine and more male hormones, vasodilator, spinal nerve stimulants, immunomodulator, immunosuppressants, such as glucocorticoid treatment. Serious infusion with fetal liver, cord blood transfusion, bone marrow transplant, pure western medicine treatment medication, side effects, it is not appropriate long-term use, we often used method of combining traditional Chinese and western medicine treatment of this disease, the cure rate with this disease greatly improved, traditional Chinese medicine treatment of this disease have to fill qi and blood, Bushen, focused on stimulating the growth of hematopoietic stem cells, the president of our hospital SU Feng Zhe treatment of this disease, according to the main barrier is the red bone marrow pathology of this fat mechanisms, “inspired Shengsui law” treatment of AA’s new methods, “inspired Shengsui Law” through a Huoxue Huayu, detoxification Shengsui Chinese medicine, on the one hand so that the fat in the bone marrow of patients myeloid been decomposition, absorption , excretion; activated bone marrow growth factor on the other hand, have a normal bone marrow hematopoietic stem cells and re-formation of red bone marrow. Replaced by the red bone marrow fat so that the blood marrow cell growth brisk, bleeding, and other symptoms of anemia quickly alleviated. Under the guidance of this theory, developed aplastic anemia Shengsui capsule, series AA JIN Dan drugs so that the patients taking a course that is a condition marked improvement in clinical symptoms eliminated, restoring blood cells.
Clinical treatment of more than 1,000 patients, a similar drug comparison, a better effect, the institutes Legislative research projects: “Health myeloid AA AA capsule treatment Clinical and Experimental Research” by the province as a key scientific research projects.